6-168033981-C-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_030615.4(KIF25):c.267C>A(p.Asp89Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000296 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_030615.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF25 | NM_030615.4 | c.267C>A | p.Asp89Glu | missense_variant | 8/13 | ENST00000643607.3 | NP_085118.2 | |
KIF25 | NM_005355.5 | c.267C>A | p.Asp89Glu | missense_variant | 8/12 | NP_005346.3 | ||
KIF25 | XM_047418749.1 | c.267C>A | p.Asp89Glu | missense_variant | 6/11 | XP_047274705.1 | ||
KIF25 | XM_011535803.4 | c.267C>A | p.Asp89Glu | missense_variant | 6/10 | XP_011534105.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF25 | ENST00000643607.3 | c.267C>A | p.Asp89Glu | missense_variant | 8/13 | NM_030615.4 | ENSP00000496229 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000398 AC: 100AN: 251442Hom.: 0 AF XY: 0.000331 AC XY: 45AN XY: 135908
GnomAD4 exome AF: 0.000287 AC: 420AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.000275 AC XY: 200AN XY: 727244
GnomAD4 genome AF: 0.000381 AC: 58AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74346
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at